Therapeutic potential of fecal microbiota transplantation.

By L. Smits, K. Bouter, W. D. de Vos, T. Borody, M. Nieuwdorp. Gastroenterology, 2013

654 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition. (2017, background): “observational studies have suggested correlations between alteredmicrobiota composition andmetabolism in humans, causality has been difficult to prove (Smits et al., 2013).”
Microbial genes, brain & behaviour – epigenetic regulation of the gut–brain axis (2014, background): “…and colleagues suggested faecal transplants may be extended from the treatment of Clostridium difficile infections to benefit patients suffering from multiple other pathological conditions, including neurodegenerative diseases such as Parkinson’s disease (Borody et al. 2000; Smits et al. 2013).”
The Gut Microbiota and Alzheimer’s Disease (2017, positive): “Anarguablyeffectivetherapyfortreat-ingpatientswith Clostridium difﬁcile infection [71, 72] (for review, see [72]), FMT has also shown favorable outcomes in extra-intestinal diseases associated with intestinal dysbiosis (for review, see [73, 74]).”